It will be important to investigate whether DHA supplementation can increase DHA levels in both the GBM microenvironment and GBM tissue, thereby paving the way to improved GBM patient outcome, by inhibiting the infiltration of FABP7-expressing GBM neural stem-like cells into brain parenchyma. The gene discussed is FABP7; the disease is glioblastoma.